CoChat
Sign Up
Cited by 60Advanced Drug Delivery SystemsInhalation and Respiratory Drug DeliveryAdvancements in Transdermal Drug Delivery

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Nose-to-brain delivery of drug nanocrystals by using Ca2+ responsive deacetylated gellan gum based in situ-nanogel

Huang, Guiting, Xie, Jin, Shuai, Shuyuan, Wei, Shaofeng, Chen, Yingchong, Guan, Zhiyu, Zheng, Qin, Yue, Pengfei, Wang, Changhong·2021·International Journal of Pharmaceutics
DOI 10.1016/j.ijpharm.2020.120182
Open this paper in CoChat — free account

Abstract

The objective of this study is to use a carbohydrate polymer deacetylated gellan gum (DGG) as matrix to design nanocrystals based intranasal in situ gel (IG) for nose-to -brain delivery of drug. The harmine nanocrystals (HAR-NC) as model drug were prepared by coupling homogenization and spray-drying technology. The HAR-NC was redispersed in the (DGG) solutions and formed the ionic-triggered harmine nanocrystals based in situ gel (HAR-NC-IG). The crystal state of HAR remained unchanged during the homogenization and spray-drying. And the HAR-NC-IG with 0.5% DGG exhibited excellent in situ-gelation ability, water retention property and in vitro release behavior. The bioavailability in brain of intranasal HAR-NC-IG were 25-fold higher than that of oral HAR-NC, which could be attributed to nanosizing effect of HAR-NC and bioadhesive property of DGG triggered by nasal fluid. And the HAR-NC-IG could significantly inhibit the expression of acetylcholinesterase (AchE) and increase the content of acetylcholin (ACh) in brain compared with those of reference formulations (p < 0.01). The DGG based nanocrystals-in situ gel was a promising carrier for nose-to-brain delivery of poorly soluble drug, which could prolong the residence time and improve the bioavailability of poorly soluble drugs in brain.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.ijpharm.2020.120182

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 1 references

Research works printed but not linked: 38

  1. Agrawal, 2018, Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs, J. Control. Release, 281, 139, 10.1016/j.jconrel.2018.05.011 · DOI · Paper page
  2. Cho, 2013, Treadmill exercise alleviates short-term memory impairment in 6-hydroxydopamine-induced Parkinson's rats, J. Exerc. Rehabil., 9, 354, 10.12965/jer.130048 · DOI · Paper page
  3. Chen, 2017, A natural triterpenoid saponin as multifunctional stabilizer for drug nanosuspension powder, AAPS Pharmscitech., 18, 2744, 10.1208/s12249-017-0756-7 · DOI
  4. Cunha, 2017, Lipid nanoparticles for nasal/intranasal drug delivery, Crit. Rev. Ther. Drug, 34, 257, 10.1615/CritRevTherDrugCarrierSyst.2017018693 · DOI
  5. Filali, 2015, Synthesis of new isoxazoline derivatives from harmine and evaluation of their anti-Alzheimer, anti-cancer and anti-inflammatory activities, J. Enzyme Inhib. Med. Chem., 30, 371, 10.3109/14756366.2014.940932 · DOI
  6. Hao, 2016, Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery, Colloids Surf. B Biointerfaces, 147, 376, 10.1016/j.colsurfb.2016.08.011 · DOI
  7. He, 2015, Effects of harmine, an acetylcholinesterase inhibitor, on spatial learning and memory of APP/PS1 transgenic mice and scopolamine-induced memory impairment mice, Eur J Pharmacol., 768, 96, 10.1016/j.ejphar.2015.10.037 · DOI
  8. Hosny, 2014, Intranasal in situ gel loaded with saquinavir mesylate nanosized microemulsion: preparation, characterization, and in vivo evaluation, Int. J. Pharm., 475, 191, 10.1016/j.ijpharm.2014.08.064 · DOI
  9. Illum, 2003, Nasal drug delivery-possibilities, problems and solutions, J. Control. Release, 87, 187, 10.1016/S0168-3659(02)00363-2 · DOI
  10. Jansson, 1983, Structural studies of gellan gum, an extracellular polysaccharide elaborated by Pseudomonas elodea, Carbohydr. Res., 124, 135, 10.1016/0008-6215(83)88361-X · DOI
  11. Jelkmann, 2020, A gellan gum derivative as in-situ gelling cationic polymer for nasal drug delivery, Int. J. Biol. Macromol., 158, 103, 10.1016/j.ijbiomac.2020.04.114 · DOI
  12. Kim, 2013, Treadmill and wheel exercise alleviate lipopolysaccharide-induced short-term memory impairment by enhancing neuronal maturation in rats, Mol. Med. Rep., 7, 31, 10.3892/mmr.2012.1160 · DOI
  13. Kumar, 2016, Nasal-nanotechnology: revolution for efficient therapeutics delivery, Drug Deliv., 23, 681, 10.3109/10717544.2014.920431 · DOI
  14. Leone, 2020, Enriched Gellan Gum hydrogel as visco-supplement, Carbohyd. Polym., 227, 115347, 10.1016/j.carbpol.2019.115347 · DOI
  15. Ma, 2018, Novel nanocrystal-based solid dispersion with high drug loading, enhanced dissolution, and bioavailability of andrographolide, Int. J. Nanomed., 13, 3763, 10.2147/IJN.S164228 · DOI
  16. Luo, 2020, Study on redispersibility of drug nanocrystals particles during storage: Novel understanding based on water adsorption and glass transition of amorphous matrix formers, Int. J. Pharm., 575, 118945, 10.1016/j.ijpharm.2019.118945 · DOI
  17. Marttin, 1998, Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs, J. Drug Target, 6, 17, 10.3109/10611869808997878 · DOI
  18. Merkus, 1993, Absorption enhancers in nasal drug delivery: efficacy and safety, J. Control. Release, 24, 201, 10.1016/0168-3659(93)90179-9 · DOI
  19. Müller, 2011, State of the art of nanocrystals-special features, production, nanotoxicology aspects and intracellular delivery, Eur. J. Pharm. Biopharm., 78, 1, 10.1016/j.ejpb.2011.01.007 · DOI
  20. Muthukumar, 2019, Biological role of gellan gum in improving scaffold drug delivery, cell adhesion properties for tissue engineering applications, Molecules, 24, 4514, 10.3390/molecules24244514 · DOI
  21. Nazar, 2011, Thermosensitive hydrogels for nasal drug delivery: The formulation and characterisation of systems based on N-trimethyl chitosan chloride, Eur. J. Pharmaceutics, 77, 225
  22. Osmalek, 2014, Application of gellan gum in pharmacy and medicine, Int. J. Pharmaceut., 466, 328, 10.1016/j.ijpharm.2014.03.038 · DOI
  23. Palumbo, 2020, Gellan gum-based delivery systems of therapeutic agents and cells, Carbohydr. Polym., 229, 115430, 10.1016/j.carbpol.2019.115430 · DOI
  24. Pardhi, 2018, Nanocrystals: an overview of fabrication, characterization and therapeutic applications in drug delivery, Curr. Pharm. Des., 24, 5129, 10.2174/1381612825666190215121148 · DOI
  25. Rajput, 2019, Resveratrol anchored nanostructured lipid carrier loaded in situ gel via nasal route: Formulation, optimization and in vivo characterization, J. Drug Delivery Sci. Technol., 51, 214, 10.1016/j.jddst.2019.01.040 · DOI
  26. Saindane, 2013, Nanosuspensions based in situ gelling nasal spray of carvedilol: development, in vitro and in vivo characterization, AAPS PharmSciTech., 14, 189, 10.1208/s12249-012-9896-y · DOI
  27. Santos, 2017, Effects of the natural β-carboline alkaloid harmine, a main constituent of Ayahuasca, in memory and in the hippocampus: a systematic literature review of preclinical studies, J. Psychoact. Drugs, 49, 1, 10.1080/02791072.2016.1260189 · DOI
  28. Singh, 2013, Mucoadhesive in situ nasal gelling drug delivery systems for modulated drug delivery, Expert Opin. Drug Deliv., 10, 115, 10.1517/17425247.2013.746659 · DOI
  29. Tang, 2011, Physical hydrogels with self-assembled nanostructures as drug delivery systems, Expert Opin. Drug Deliv., 8, 1141, 10.1517/17425247.2011.588205 · DOI
  30. Wang, 2012, Formulation and evaluation of microemulsion-based in situ ion-sensitive gelling systems for intranasal administration of curcumin, J. Drug Target, 20, 831, 10.3109/1061186X.2012.719230 · DOI
  31. Wang, 2013, In situ gel-forming system: an attractive alternative for nasal drug delivery, Crit. Rev. Ther. Drug Carrier Syst., 30, 411, 10.1615/CritRevTherDrugCarrierSyst.2013007362 · DOI
  32. Wei, 2018, Hyaluronic acid based nanocrystals hydrogels for enhanced topical delivery of drug: a case study, Carbohydr. Polym., 202, 64, 10.1016/j.carbpol.2018.08.112 · DOI
  33. Wu, 2019, Intranasal delivery of paeoniflorin nanocrystals for brain targeting, Asian J Pharm., 15, 326
  34. Yang, 2015, Potent AChE and BChE inhibitors isolated from seeds of Peganum harmala Linn by a bioassay-guided fractionation, J. Ethnopharmacol., 168, 279, 10.1016/j.jep.2015.03.070 · DOI
  35. Yue, 2013, Process optimization and evaluation of novel baicalin solid nanocrystals, Int. J. Nanomed., 8, 2961, 10.2147/IJN.S44924 · DOI
  36. Yue, 2013, Study on formability of solid nanosuspensions during nanodispersion and solidification: I. Novel role of stabilizer/drug property, Int. J. Pharm., 454, 269, 10.1016/j.ijpharm.2013.06.050 · DOI
  37. Yue, 2015, The importance of solidification stress on the redispersibility of solid nanocrystals loaded with harmine, Int. J. Pharm., 480, 107, 10.1016/j.ijpharm.2015.01.037 · DOI
  38. Zaki, 2007, Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties, Eur. J. Pharm. Sci., 32, 296, 10.1016/j.ejps.2007.08.006 · DOI

Cited by

Sorted by citations

Metadata

Authors
Huang, G., Xie, J., Shuai, S., Wei, S., Chen, Y., Guan, Z., Zheng, Q., Yue, P., & Wang, C.
Affiliations
  • Jiangxi University of Traditional Chinese Medicine (CN)
  • Shanghai University of Traditional Chinese Medicine (CN)
Corresponding author
  • Yue, Pengfei
  • Wang, Changhong
ORCID
Venue
International Journal of Pharmaceutics
Publisher
Elsevier BV
Published
2021-02
Volume
594
Pages
120182
ISSN
0378-5173 (ISSN-L)
DOI
10.1016/j.ijpharm.2020.120182
OpenAlex
W3113261592
Cited by
60
References
1
Citations by year
2026: 7 · 2025: 10 · 2024: 14 · 2023: 14 · 2022: 10 · 2021: 5
FWCI
2.82
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • International Journal of Pharmaceutics (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
Keywords
nose-to-brain delivery, harmine, in situ gel, drug nanocrystals, intranasal drug delivery, poorly water-soluble drugs, brain bioavailability, acetylcholinesterase inhibition, acetylcholine, spray drying, homogenization, bioadhesion, nasal fluid
MeSH terms
Nanogels, Brain, Gels, Polysaccharides, Bacterial, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review